PA
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.526
Exchange
XNAS - Nasdaq
-0.054 B
Last period CFO ,USD
-209%
CFO has decreased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Pacific Biosciences
Company Analysis
PACB valuation, rating, competitors, insights and company profile
Eyestock Rating
PACB financial analysis by Eyestock methodology
Valuation
PACB valuation using historical relative method
Statements
PACB Income Statements, Balance Sheet and Cash Flow Statements
Dividends
PACB dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Pacific Biosciences`s CFO for the period ended 2024-06-30 is -0.054 B USD
